Finally, TDP1 is a drug target for spinocerebellar ataxia type 1 with axonal neuropathy(Hirano et al. 2007), which correlates with cardiac autonomic dysfunction, predominantly parasympathetic(Pradhan et al. 2008). Here, TDP1 is linked to spinocerebellar ataxia type 1.